Episode 25: Jim Geraghty, Author and Biotech Industry Veteran

Episode 25 November 17, 2022 00:39:44
Episode 25: Jim Geraghty, Author and Biotech Industry Veteran
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 25: Jim Geraghty, Author and Biotech Industry Veteran

Nov 17 2022 | 00:39:44

/

Show Notes

“We can’t take the orphan drug revolution for granted.“ Biorasi’s Few & Far Between Podcast welcomes Jim Geraghty, author and biotech industry veteran, to discuss the necessity and viability of orphan and rare disease research - for both patients and VC investors alike.

 

Other Episodes

Episode 61

October 01, 2025 00:45:18
Episode Cover

Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics

Why is a feather-light touch important in fighting infections? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host...

Listen

Episode 32

August 17, 2023 00:37:05
Episode Cover

Episode 32: Stephanie Wisner, Author, Co-Founder at Centivax

"In research or in biotech, time is expensive. Time is the most expensive thing that you have." - Stephanie Wisner, Author, Co-Founder at Centivax...

Listen

Episode 22

July 26, 2022 00:23:58
Episode Cover

Episode 22: Dr. Jocelynn Pearl, Senior Scientist at Tune Therapeutics, Host of Lady Scientist Podcast

How can DAOs - Decentralized Autonomous Organizations - improve rare disease research? Biorasi's Few & Far Between Podcast welcomes Dr. Jocelynn Pearl, Senior Scientist...

Listen